October 15, 2008 - Boston Scientific Corp. announced estimated U.S. market shares for September for its two drug-eluting ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
October 15, 2008 - The new name and branding for MEDRAD’s interventional products division was unveiled to the public at ...
October 15, 2008 – At TCT 2008, Boston Scientific Corp. announced 12-month left main and three-vessel disease subset ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
October 14, 2008 - St. Jude Medical Inc. said today at TCT 2008 that the FDA and European CE Mark approval of the ...
October 14, 2008 – Medtronic released, at TCT 2008, new data from the ENDEAVOR clinical program that reinforces the ...
October 13, 2008 — Data from an independent meta-analysis of Abbott Vascular’s SPIRIT II and SPIRIT III randomized ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
October 12, 2008 – Research results indicate that optical coherence tomography (OCT) may be the best tool ...
October 13, 2008 - Of those treated with Medtronic’s Endeavor Resolute drug-eluting stent (DES) in the RESOLUTE IDE ...
October 13, 2008 – GE Healthcare is featuring real-time imaging solutions made possible, in part, by new ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
October 13, 2008 – At TCT 2008, Boston Scientific Corp. announced results from an analysis of nearly 7,500 patients from ...
October 13, 2008 - Boston Scientific Corp. released comprehensive data for the TAXUS ATLAS clinical program, a series of ...
October 10, 2008 - Boston Scientific Corp. today said it received FDA approval to market its second-generation ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
October 9, 2008 - Lumen Biomedical Inc. said today the FDA cleared the LBI Embolectomy System for use in the removal of ...
October 9, 2008 - Boston Scientific Corp. yesterday said it completed enrollment in the PERSEUS trial, designed to ...
October 8, 2008 - SurModics Inc. today said the PROTEX Coronary Stent System incorporating SurModics’ proprietary Finale ...
October 14, 2008